Ergoteles’s Privia Health PRVA Stock Holding History

Ergoteles’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28,610	Closed	-$740K	–	1562
2021 Q4	$740K	Sell	28,610 -86,501	-75%	-$2.16M	0.03%	503
2021 Q3	$2.71M	Buy	+115,111	New	+$4.02M	0.1%	226

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's PRVA Position: Q1 2022 in Review

Ergoteles sold out of Privia Health (PRVA) in Q1 2022, closing a stake of 28,610 shares — an estimated $740K sold.

Ergoteles first reported a position in PRVA in Q3 2021 and held it in 2 quarters. The position peaked at $2.71M in Q3 2021. 146 funds tracked by Wall St. Rank hold PRVA as of Q1 2022.

Ergoteles reported no remaining Privia Health position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 28,610 Privia Health shares in Q1 2022, an estimated $740K.
Ergoteles first reported a position in Privia Health in Q3 2021 and held it in 2 quarters.
Ergoteles's Privia Health position peaked at $2.71M in Q3 2021.
146 funds tracked by Wall St. Rank held Privia Health as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.